Giulia Petrone
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Giulia Petrone as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06240754 · Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized TrialWashington University School of Medicine · recruiting · Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:48 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- 101 citationsRCR 4.6
- Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors.Clin Breast Cancer · 201266 citationsRCR 2.0
- Localized ridge augmentation using titanium micromesh.J Oral Implantol · 200129 citationsRCR 1.4